DCF — THEDACARE MEDICAL CENTER-NEW LONDON
Enterprise Value: $28.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$28.8M
Enterprise Value
$7.5M
PV of Cash Flows
$21.3M
PV of Terminal Value
$34.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $38.7M | $3.8M | 10.0% | $1.4M | $1.3M |
| Year 2 | $39.9M | $4.3M | 11.0% | $1.8M | $1.5M |
| Year 3 | $41.1M | $4.8M | 12.0% | $2.1M | $1.6M |
| Year 4 | $42.3M | $5.2M | 12.0% | $2.4M | $1.6M |
| Year 5 | $43.6M | $5.4M | 12.0% | $2.5M | $1.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $28.8M. Terminal value accounts for 74% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$37.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.09221854530548629
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5